"Our goal and mission as an organization is to improve the lives of all human beings suffering from medical conditions. By contributing with pharmaceutical sponsors and CROs in the development of new treatments, we can offer our patients and everyone who is willing an alternative to potentially improve their medical condition."

During the past decade, Wellness Clinical Research conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 8 clinical trials were completed, i.e. on average, 38.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wellness Clinical Research" #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Pfizer" with 3 trials sponsored, "Exact Sciences Corporation" with 2 trials sponsored and "Reistone Biopharma Company Limited" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wellness Clinical Research" #1 collaborator was "Dermira, Inc." with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Wellness Clinical Research" are "Ulcerative Colitis" (5 trials), "Crohn's Disease" (3 trials), "Atopic Dermatitis" (2 trials), "Colorectal Cancer" (2 trials) and "Crohn Disease" (2 trials). Many other conditions were trialed in "Wellness Clinical Research" in a lesser frequency.

Most popular intervention types in "Wellness Clinical Research" are "Drug" (16 trials), "Other" (4 trials), "Biological" (2 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Etrolizumab" (4 trials), "Mirikizumab" (3 trials), "Adalimumab" (2 trials) and "Lebrikizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wellness Clinical Research" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Wellness Clinical Research". undefined are not yet recruiting, 2 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Wellness Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wellness Clinical Research, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".